Clinical Trial Update: Attention Bias Modification Treatment (ABMT) for Patients With Post Traumatic Stress Disorder (PTSD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Attention Bias Modification Treatment for post-traumatic stress disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Snippet

Sponsor: Tel Aviv University | Conditions: Attention Bias Modification Treatment (ABMT) | Phase 2 | Status: COMPLETED